Podcast: Listen
Dr. Gogoi is an active clinician and cancer researcher with an interest in studying the role of the HIPPO pathway in gynecologic cancers as an opportunity to identify new therapeutic approaches for treatment. Her health services and epidemiology research are focused on evaluating new opportunities to implement HPV vaccine education in underserved populations.
Prior to joining Karmanos, Dr. Gogoi was a Women's Health Research Scholar at the University of Colorado where she received her Doctor of Philosophy degree in Molecular Biology and was practicing as a gynecologic oncologist at Geisinger Medical Center in Danville, Penn., for the last 10 years.
Dr. Gogoi is board certified in Gynecologic Oncology and Obstetrics and Gynecology. She is a member of the Society for Gynecologic Oncology, the International Gynecologic Cancer Society (IGCS) and the American Society of Clinical Oncology (ASCO).
Karmanos Cancer Institute in Michigan offers innovative surgical options for many different types of cancer. Surgery for the treatment of cancer is just one approach to fighting the disease.
Karmanos is pleased to congratulate Radhika Gogoi, M.D., Ph.D. , member of the Gynecologic Oncology Multidisciplinary Team at Karmanos for securing a Geri Fournier Ovarian Cancer Research Grant in the amount of $50,000. The annual award is given by The Michigan Ovarian Cancer Alliance to recognize and provide funding for the critical research happening in the state. Dr. Gogoi received the grant award for a research project that aims to identify differences between BRCA1 and BRCA2 proteins that may lead ...
The Karmanos Cancer Institute at McLaren Flint is expanding to fulfill the increasing need for oncology services in Genesee County with the addition of four highly respected Karmanos Cancer Institute physicians. Robert Morris, M.D .; Radhika P. Gogoi, M.D., Ph.D. .; John J. Wallbillich, M.D .; and Ira S. Winer, M.D., Ph.D . are joining the comprehensive cancer care team at Karmanos Cancer Institute at McLaren Flint to bring advanced care for cancers of the female reproductive system to the community. “W...
*Indicates required information